Produktbild: CNS Drug Development and Delivery
Band 9999

CNS Drug Development and Delivery Concepts and Applications

156,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

14.07.2025

Herausgeber

Alan Talevi

Verlag

Springer

Seitenzahl

230

Maße (L/B/H)

23,5/15,5/1,4 cm

Gewicht

371 g

Sprache

Englisch

ISBN

978-3-031-62606-7

Beschreibung

Portrait

Prof. Alan Talevi was born in Buenos Aires, 1980. He obtained his Pharmacy degree in 2004 and completed his PhD studies in 2007, both at the University of La Plata (UNLP, Argentina). Among other recognitions, he obtained the award for the best PhD thesis on Computational Chemistry from the Argentinean Chemical Society (2008), a Pacifichem Young Scholar Award (USA, 2010) and the Award to Scientific and Technological Production from UNLP (2016). Since 2010, he holds a permanent position at the Argentinean Council of Scientific and Technical Research (CONICET), where he currently occupies a Principal Researcher position, and he is a Full Professor (tenured) in charge of the Biopharmacy/Pharmacokinetics course at the Faculty of Exact Sciences, UNLP. He has published over 100 articles in periodicals and more than 80 book chapters/entries, mostly in the fields of machine learning, drug discovery and biopharmaceutics.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

14.07.2025

Herausgeber

Alan Talevi

Verlag

Springer

Seitenzahl

230

Maße (L/B/H)

23,5/15,5/1,4 cm

Gewicht

371 g

Sprache

Englisch

ISBN

978-3-031-62606-7

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: CNS Drug Development and Delivery
  • Chapter 1- Transporter-mediated drug delivery to the brain.- Chapter 2 - Mechanisms and methods for evaluating drug delivery via transcytosis to the brain.- Chapter 3 -In vitro blood-brain studies.- Chapter 4 - In silico prediction of CNS bioavailability.- Chapter 5 - Use of unbound exposure data to establish in vitro-in vivo correlations for CNS drug candidates.- Chapter 6 - Intranasal Delivery of Drugs to the Central Nervous System.- Chapter 7 - Polymeric nanoparticles for nose-to-brain delivery in Alzheimer's and Parkinson¿s diseases.- Chapter 8 - Barriers of the CNS and their contribution to drug-resistant epilepsy.- Chapter 9 - Network-pharmacology and central nervous system drug development.